Boc-Cys(Trt)-OHCAS# 21947-98-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 21947-98-8 | SDF | Download SDF |
PubChem ID | 89557 | Appearance | Powder |
Formula | C27H29NO4S | M.Wt | 463.6 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-tritylsulfanylpropanoic acid | ||
SMILES | CC(C)(C)OC(=O)NC(CSC(C1=CC=CC=C1)(C2=CC=CC=C2)C3=CC=CC=C3)C(=O)O | ||
Standard InChIKey | JDTOWOURWBDELG-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C27H29NO4S/c1-26(2,3)32-25(31)28-23(24(29)30)19-33-27(20-13-7-4-8-14-20,21-15-9-5-10-16-21)22-17-11-6-12-18-22/h4-18,23H,19H2,1-3H3,(H,28,31)(H,29,30) | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Boc-Cys(Trt)-OH Dilution Calculator
Boc-Cys(Trt)-OH Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.157 mL | 10.7852 mL | 21.5703 mL | 43.1406 mL | 53.9258 mL |
5 mM | 0.4314 mL | 2.157 mL | 4.3141 mL | 8.6281 mL | 10.7852 mL |
10 mM | 0.2157 mL | 1.0785 mL | 2.157 mL | 4.3141 mL | 5.3926 mL |
50 mM | 0.0431 mL | 0.2157 mL | 0.4314 mL | 0.8628 mL | 1.0785 mL |
100 mM | 0.0216 mL | 0.1079 mL | 0.2157 mL | 0.4314 mL | 0.5393 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Boc-Cys(Trt)-OH
- trans-Cinnamic anhydride
Catalog No.:BCN7914
CAS No.:21947-71-7
- Boc-Nle-OH.DCHA
Catalog No.:BCC3297
CAS No.:21947-32-0
- H-ß-HoIle-OH.HCl
Catalog No.:BCC3235
CAS No.:219310-10-8
- 2-Hydroxy-3,4,5,6-tetramethoxychalcone
Catalog No.:BCN1489
CAS No.:219298-74-5
- Hydroxyzine 2HCl
Catalog No.:BCC4519
CAS No.:2192-20-3
- Ac-YVAD-AFC
Catalog No.:BCC4022
CAS No.:219137-85-6
- 3'-Methoxydaidzein
Catalog No.:BCN4082
CAS No.:21913-98-4
- 2,3-Dihydro-3-methoxywithaferin A
Catalog No.:BCN7943
CAS No.:21902-96-5
- Boc-ß-HoGlu(OBzl)-OH
Catalog No.:BCC3233
CAS No.:218943-30-7
- Z-Trp(Boc)-OH.DCHA
Catalog No.:BCC2749
CAS No.:218938-57-9
- KNK437
Catalog No.:BCC6399
CAS No.:218924-25-5
- Euphorbia factor L8
Catalog No.:BCN3785
CAS No.:218916-53-1
- Littorine
Catalog No.:BCN1917
CAS No.:21956-47-8
- Trans-Pinosylvin dimethyl ether
Catalog No.:BCN3495
CAS No.:21956-56-9
- PD 173074
Catalog No.:BCC3662
CAS No.:219580-11-7
- 4',7-Dihydroxyflavone
Catalog No.:BCN3758
CAS No.:2196-14-7
- beta-Hydroxypropiovanillone
Catalog No.:BCN4938
CAS No.:2196-18-1
- (R)-Coclaurine
Catalog No.:BCN8348
CAS No.:2196-60-3
- Griffipavixanthone
Catalog No.:BCN4939
CAS No.:219649-95-3
- Baicalin
Catalog No.:BCN5901
CAS No.:21967-41-9
- 14-Deoxy-12-hydroxyandrographolide
Catalog No.:BCN4673
CAS No.:219721-33-2
- Taxezopidine L
Catalog No.:BCN6946
CAS No.:219749-76-5
- ANA 12
Catalog No.:BCC6287
CAS No.:219766-25-3
- Bombiprenone
Catalog No.:BCN4940
CAS No.:21978-49-4
Preparation of protected peptidyl thioester intermediates for native chemical ligation by Nalpha-9-fluorenylmethoxycarbonyl (Fmoc) chemistry: considerations of side-chain and backbone anchoring strategies, and compatible protection for N-terminal cysteine.[Pubmed:15787970]
J Pept Res. 2005 Mar;65(3):395-410.
Native chemical ligation has proven to be a powerful method for the synthesis of small proteins and the semisynthesis of larger ones. The essential synthetic intermediates, which are C-terminal peptide thioesters, cannot survive the repetitive piperidine deprotection steps of N(alpha)-9-fluorenylmethoxycarbonyl (Fmoc) chemistry. Therefore, peptide scientists who prefer to not use N(alpha)-t-butyloxycarbonyl (Boc) chemistry need to adopt more esoteric strategies and tactics in order to integrate ligation approaches with Fmoc chemistry. In the present work, side-chain and backbone anchoring strategies have been used to prepare the required suitably (partially) protected and/or activated peptide intermediates spanning the length of bovine pancreatic trypsin inhibitor (BPTI). Three separate strategies for managing the critical N-terminal cysteine residue have been developed: (i) incorporation of N(alpha)-9-fluorenylmethoxycarbonyl-S-(N-methyl-N-phenylcarbamoyl)sulfenylcystein e [Fmoc-Cys(Snm)-OH], allowing creation of an otherwise fully protected resin-bound intermediate with N-terminal free Cys; (ii) incorporation of N(alpha)-9-fluorenylmethoxycarbonyl-S-triphenylmethylcysteine [Fmoc-Cys(Trt)-OH], generating a stable Fmoc-Cys(H)-peptide upon acidolytic cleavage; and (iii) incorporation of N(alpha)-t-butyloxycarbonyl-S-fluorenylmethylcysteine [Boc-Cys(Fm)-OH], generating a stable H-Cys(Fm)-peptide upon cleavage. In separate stages of these strategies, thioesters are established at the C-termini by selective deprotection and coupling steps carried out while peptides remain bound to the supports. Pilot native chemical ligations were pursued directly on-resin, as well as in solution after cleavage/purification.
Cysteine-S-trityl a key derivative to prepare N-methyl cysteines.[Pubmed:18020422]
J Comb Chem. 2008 Jan-Feb;10(1):69-78.
S-Trt Cys are used as precursors for the synthesis of protected NMe-Cys. N-Methylation of Alloc-Cys(Trt)-OH and Boc-Cys(Trt)-OH gives the corresponding N-methylated derivatives in good yields and purities, which can be further derivatized in solution to obtain a myriad of S-protected derivatives. To further broaden the scope of this methodology, the N (alpha)-amino protecting group of the NMe- S-protected Cys can be replaced easily either on the solid phase (from the Alloc precursor) or in solution (from the Boc precursor). Thus, this convenient route allows us to obtain many different protected NMe-Cys, which were of limited accessibility until now.
Synthesis and acid ionization constants of cyclic cystine peptides H-Cys-(Gly)n-Cys-OH (n = 0-4).[Pubmed:2599775]
Int J Pept Protein Res. 1989 Oct;34(4):346-51.
Cyclic peptide disulfides of the general formula H-Cys-(Gly)n-Cys-OH (n = 0-4) were synthesized from the corresponding peptide derivatives [Boc-Cys(Trt)(Gly)-n-Cys(Trt)-OBut] by oxidation with iodine in methanol and by subsequent removal of the terminal groups with trifluoroacetic acid. Acid ionization constants of the obtained peptides were determined by potentiometric titration in aqueous KCl (0.1 mol/L) medium. All compounds have two dissociable hydrogens, corresponding to carboxyl (pK1 = 2.35-2.84) and to terminal amino group (pK2 = 5.61-6.93); pK1 values show first an upward and then a downward trend with the increase in ring size; the opposite is true for pK2 values. These trends could be tentatively attributed to the intramolecular salt bridge (-COO- ----NH+3-) formation.
Protection of asparagine and glutamine during N alpha-Bpoc-based solid-phase peptide synthesis.[Pubmed:8740971]
Int J Pept Protein Res. 1996 Mar;47(3):209-13.
In this paper we describe the synthesis and properties of Bpoc-Asn(Trt)-OH, Bpoc-Asn(Trt)-OPfp, Bpoc-Gln(Trt)-OH and Bpoc-Gln(Trt)-OPfp. These derivatives are highly soluble in CH2Cl2 and can be coupled efficiently in solid-phase peptide synthesis. The peptides, acetyl-Ala-Phe-Asn(Trt)-Gly-Leu-Ala-O-Dbf-SH and Boc-Cys(Acm)-Ala-Phe-Gln(Trt)-Gly-Leu-Ala-O-Dbf-SH (where O-Dbf-SH is the peptide ester of 4-mercapto-6-hydroxydibenzofuran) were synthesized by stepwise solid-phase peptide synthesis using N alpha-Bpoc amino acids. We have observed that less than 0.1% of the trityl group is removed from the carboxamide of Gln and Asn during a standard 15 min N alpha-Bpoc deprotection in 0.5% TFA in CH2Cl2.